TDOC has a very good platform and it is way more functional than FaceTime. One good thing they are doing is partnering with payers, not trying to take away their business. I think they signed a deal with Aetna to become their official telemedicine platform. Microsoft vs Apple business model.
I’m somewhat in your camp but can’t stomach the tax liability if I sell. I’ll just have to buy more to DCA.
Again, I don’t want to cost anyone money if they think TDOC is a winner, but my prediction is that it goes nowhere but down. All of the competitors like Kareo and Klara, not to mention the likes of BlueJeans Telehealth (owned by VZ) claim to be #1. At what I’m not sure b/c it’s Impossible to decipher which services actually do what. But, I digress…that’s all I got to say about that…
Sweating the tax liability has cost me more money over my investing lifetime by not selling than just paying Uncle Sam.
My observations have been stocks that are up huge in extended sell off a bit just after the market opens, and then recovers. And vice versa.
Probably true, but still sucks! Thankfully, the vast majority of our investments are via tax-deferred accounts. However, that is changing a bit.
No BTC mining, no BTC. Didn't hear the news until your post, so thanks for the heads up. I assumed BTC and crypto were crushing due to the Fed like the stock market!
Maybe wife tells me that a lot of insurances are no longer covering virtual visits at the same rate as in person visits. I am not sure how TDOC would be affected by that. My guess is that it will be negative.
Yes, be careful with price to sales companies. Some will bottom out and be worth a small position. However, established tech is becoming irresistible. Look at FB.....8:1 price to sales, 20:1 price to earnings, annual growth 20%+. Buy, buy, buy. Too good to pass up.
I am not talking about about the high growth companies with reasonable PE's (AAPL, FB, GOOG, MSFT, etc). I was mostly referring to high flying growth stocks that may not become profitable for several years. There are a lot of imposters in the high growth area just like the dot com bubble.
Agreed, be careful, but some good opportunities. During the dot com bubble, many "companies" were just concepts without any real products yet. At least most high fliers today have sales.
Works for me. I like the 3 of those names and if they go down more pucker up baby lol.
The crypto retail buyers are the weakest hands of all so they’ll sell the second they are scared. Same goes for the stock market. All the new entrants in the last 2 years have yet to be tested in a real correction. Those guys are going to be the first to crap their pants.
What goes up is bound to come down and what goes down is bound to go back up! The question for ARKK is whether there is a better choice for that 4% allocation right now. I think the answer is yes. The new choice depends on your other ETFs and market coverage.
As far as I’m concerned a fund like ARKK is one of the easiest to evaluate. Just look at the top holdings. If those companies aren’t positioned for success in the new rate environment there could be more downside ahead, at least in 6-12 months. Also, must consider that earnings are starting to matter now and spec tech may take years to recover.
Without commenting on allocations, nothing wrong with VTI and IGM. I’m not an international fund guy because my research always brought me back to the same conclusion and belief = when times are good, US outperforms; when times are bad, US outperforms.
IGM is a great ETF. I would just bump that up to 15% and call it a day. Otherwise, play the value game and check out VTV for your final 5%.
Caveat: I’m not suggesting VXUS isn’t a good way to diversify your portfolio away from US exposure. I’m just saying I’d rather bet on the US.
So to confirm, you both think just cut losses with ARKK at this time?
You should have cut your losses before the new year if it was in a taxable account and then get back in when prices are low enough and you have a comfort level to rebuy. NVM if its in a tax deferred account.
Yes, I think you should get out of ARKK. I did so last summer. I believe spec tech will continue to have a rough next 6 months or so. I also believe IGM will rebound quicker and outperform ARKK.
I’d be interested in hearing some other perspectives from folks on ARKK at current levels because I don’t see it returning to ATHs at any point in near future. Too many spec tech and COVID WFH plays for my taste.
I added some to my FB, GOOG, started CRM and NVDA. If they continue to fall, I add more.
Awhile back I mentioned CRM around 240 might be an okay area. I've been tempted but still haven't gone in even with the drop below 240. Ideally 190s-low 200s is a good area of support and don't think I'd chicken out there. Don't know if it'll get there though.